Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NLC Health Ventures is a leading European healthtech venture builder and early-stage investor that specializes in bridging the gap between scientific discoveries and market-ready solutions. The company operates a unique venture-building model that identifies promising healthcare innovations from universities and research institutes and transforms them into independent startups. With a portfolio of over 100 ventures, NLC focuses on four primary domains: therapeutics, medical devices, diagnostics, and digital health. Their therapeutic pipeline includes diverse modalities such as small molecules and gene therapies targeting high unmet needs in oncology, neurology, and cardiovascular disease. By providing operational support, capital, and a vast network of experts, NLC aims to accelerate the delivery of transformative health technologies to patients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health Ventures.